Stock Alert: NanoViricides Signs MoU For Human Coronavirus Drug Development License; Stock Up 10%

Shares of NanoViricides Inc. (NNVC) are rising over 10% in pre-market today, after the company announced that it has signed a Memorandum of Understanding or MoU with respect to anti-viral treatments for coronavirus derived human infections with TheraCour Pharma Inc.

from RTT - Before the Bell https://ift.tt/2MKQvnk
via IFTTT